Research suggests that cannabis use is associated with potential therapeutic benefits but also individual health harms, particularly for adolescent populations. Evidence is inconsistent and, in some ...

In this article, we outline actionable strategies for strengthening one of the most essential administrative data ...

The “it’s the prices” narrative focuses attention on a set of fee-schedule-oriented policies (some of which, as noted above, I support). The concern I have is that this narrative focuses attention ...

With a growing demand for mental health and substance use disorder services, states should think creatively about policies to extend and grow the workforce.

The financial viability of rural hospitals has been a matter of serious concern, with ongoing closures affecting rural residents’ access to medical services. We examined the financial viability of ...

Multi-year coverage potentially improves the value of insurance by making it easier for insurers to pool high- and low-risk ...

It is not currently understood whether the COVID-19 pandemic led to a lengthy period of elevated mortality rates or whether rates have returned to prepandemic trends. To examine this, I calculated age ...

During the past two decades in the United States, all major payer types—commercial, Medicare, Medicaid, and multipayer coalitions—have introduced value-based purchasing (VBP) contracts to reward ...

Maryland hospitals have operated under all-payer global budget models since 2014. Within Medicare, evaluations have estimated the resulting cost savings to be $1.6 billion for the period 2014–22. To ...

The FDA should improve device safety by increasing the amount and availability of information about previously marketed ...

Renee Gross, JD, is the community behavioral health initiatives lead for Kaiser Permanente.

The US pays higher drug prices than do peer nations, thereby financing a disproportionate share of global pharmaceutical research and development. President Donald Trump has announced himself willing ...